nach oben

Erschienen in:

01.04.2018 | ORIGINAL ARTICLE

Chronic Mild Hyperhomocysteinemia Alters Inflammatory and Oxidative/Nitrative Status and Causes Protein/DNA Damage, as well as Ultrastructural Changes in Cerebral Cortex: Is Acetylsalicylic Acid Neuroprotective?

verfasst von: Daniella de S. Moreira, Paula W. Figueiró, Cassiana Siebert, Caroline A. Prezzi, Francieli Rohden, Fatima C. R. Guma, Vanusa Manfredini, Angela T. S. Wyse

Erschienen in: Neurotoxicity Research | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Homocysteine is a sulfur-containing amino acid derived from methionine metabolism. When plasma homocysteine levels exceed 10–15 μM, there is a condition known as hyperhomocysteinemia, which occur as a result of an inborn error of methionine metabolism or by non-genetic causes. Mild hyperhomocysteinemia is considered a risk factor for development of neurodegenerative diseases. The objective of the present study was to evaluate whether acetylsalicylic acid has neuroprotective role on the effect of homocysteine on inflammatory, oxidative/nitrative stress, and morphological parameters in cerebral cortex of rats subjected to chronic mild hyperhomocysteinemia. Wistar male rats received homocysteine (0.03 μmol/g of body weight) by subcutaneous injections twice a day and acetylsalicylic acid (25 mg/Kg of body weight) by intraperitoneal injections once a day from the 30th to the 60th postpartum day. Control rats received vehicle solution in the same volume. Results showed that rats subjected to chronic mild hyperhomocysteinemia significantly increased IL-1β, IL-6, and acetylcholinesterase activity and reduced nitrite levels. Homocysteine decreased catalase activity and immunocontent and superoxide dismutase activity, caused protein and DNA damage, and altered neurons ultrastructure. Acetylsalicylic acid totally prevented the effect of homocysteine on acetylcholinesterase activity and catalase activity and immunocontent, as well as the ultrastructural changes, and partially prevented alterations on IL-1β levels, superoxide dismutase activity, sulfhydryl content, and comet assay. Acetylsalicylic acid per se increased DNA damage index. In summary, our findings showed that chronic chemically induced model of mild hyperhomocysteinemia altered some parameters and acetylsalicylic acid administration seemed to be neuroprotective, at least in part, on neurotoxicity of homocysteine.

Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126. https://doi.org/10.1016/S0076-6879(84)05016-3 PubMedCrossRef

Aksenov MY, Markesbery WR (2001) Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer’s disease. Neurosci Lett 302(2-3):141–145. https://doi.org/10.1016/S0304-3940(01)01636-6 PubMedCrossRef

Almeida OP, Flicker L, Yeap BB, Alfonso H, McCaul K, Hankey GJ (2012) Aspirin decreases the risk of depression in older men with high plasma homocysteine. Transl Psychiatry 2(8):e151. https://doi.org/10.1038/tp.2012.79 PubMedPubMedCentralCrossRef

Asanuma M, Nishibayashi-Asanuma S, Miyazaki I, Kohno M, Ogawa N (2001) Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J Neurochem 76(6):1895–1904. https://doi.org/10.1046/J.1471-4159.2001.00205.X PubMedCrossRef

Banecka-Majkutewicz Z, Sawuła W, Kadziński L, Węgrzyn A, Banecki B (2012) Homocysteine, heat shock proteins, genistein and vitamins in ischemic stroke—pathogenic and therapeutic implications

Biasibetti-Brendler H, Schmitz F, Pierozan P, Zanotto BS, Prezzi CA, de Andrade RB, Wannmacher CMD, Wyse ATS (2017) Hypoxanthine induces neuroenergetic impairment and cell death in striatum of young adult Wistar rats. Mol Neurobiol:1–9. https://doi.org/10.1007/s12035-017-0634-z

Boldyrev A, Bryushkova E, Mashkina A, Vladychenskaya E (2013) Why is homocysteine toxic for the nervous and immune systems? Curr Aging Sci 6(1):29–36. https://doi.org/10.2174/18746098112059990007 PubMedCrossRef

Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ (2001) Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci 21(15):5528–5534PubMed

Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding. Anal Biochem 72(1-2):248–254. https://doi.org/10.1016/0003-2697(76)90527-3 PubMedCrossRef

Butz LW, du Vigneaud V (1932) The formation of a homologue of cysteine by the decomposition of methionine with sulphuric acid. J Biol Chem 99:135–142

Cahill CM, Rogers JT (2008) Interleukin (IL) 1β induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IκB kinase α pathway targeting activator protein-1. J Biol Chem 283(38):25900–25912. https://doi.org/10.1074/jbc.M707692200 PubMedPubMedCentralCrossRef

Castro R, Rivera I, Blom HJ, Jakobs C, Tavares de Almeida I (2006) Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis 29(1):3–20. https://doi.org/10.1007/s10545-006-0106-5 PubMedCrossRef

Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN, FitzGerald GA (2001) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345(25):1809–1817. https://doi.org/10.1056/NEJMoa003199 PubMedCrossRef

Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, Chen MF, Pai A, John SW, Smith RS, Bottiglieri T, Bagley P, Selhub J, Rudnicki MA, James SJ, Rozen R (2001) Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 10(5):433–443. https://doi.org/10.1093/hmg/10.5.433 PubMedCrossRef

Chen H, Zhang SM, Hernán MA, Schwarzschild MA, Willett WC, Colditz GA, Speizer FE, Ascherio A (2003) Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 60(8):1059–1064. https://doi.org/10.1001/archneur.60.8.1059 PubMedCrossRef

Chen J, Zuo S, Wang J, Huang J, Zhang X, Liu Y, Zhang Y, Zhao J, Han J, Xiong L, Shi M, Liu Z (2014) Aspirin promotes oligodendrocyte precursor cell proliferation and differentiation after white matter lesion. Front Aging Neurosci 6:1–10. https://doi.org/10.3389/fnagi.2014.00007

Da Cunha AA, Ferreira AGK, Da Cunha MJ, Pederzolli CD, Becker DL, Coelho JG, Dutra-Filho CS, Wyse ATS (2011) Chronic hyperhomocysteinemia induces oxidative damage in the rat lung. Mol Cell Biochem 358(1-2):153–160. https://doi.org/10.1007/s11010-011-0930-2 PubMedCrossRef

Da Cunha AA, Ferreira AGK, Loureiro SO, Da Cunha MJ, Schmitz F, Netto CA, Wyse ATS (2012) Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats. Neurochem Res 37(8):1660–1669. https://doi.org/10.1007/s11064-012-0769-2 PubMedCrossRef

Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7(2):88–95. https://doi.org/10.1016/0006-2952(61)90145-9 PubMedCrossRef

Faraci FM (2003) Hyperhomocysteinemia: a million ways to lose control. Arterioscler Thromb Vasc Biol 23(3):371–373. https://doi.org/10.1161/01.ATV.0000063607.56590.7F PubMedCrossRef

Faraci FM, Lentz SR (2004) Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 35(2):345–347. https://doi.org/10.1161/01.STR.0000115161.10646.67 PubMedCrossRef

Förstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33:829–837, 837a–837d. https://doi.org/10.1093/eurheartj/ehr304 PubMedCrossRef

Gori AM, Corsi AM, Fedi S, Gazzini A, Sofi F, Bartali B, Bandinelli S, Gensini GF, Abbate R, Ferrucci L (2005) A proinflammatory state is associated with hyperhomocysteinemia in the elderly. Am J Clin Nutr 82(2):335–341PubMedCrossRef

Graham IM, O’Callaghan P (2002) Vitamins, homocysteine and cardiovascular risk. Cardiovasc Drugs Ther 16(5):383–389. https://doi.org/10.1023/A:1022126100625 PubMedCrossRef

Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126(1):131–138. https://doi.org/10.1016/0003-2697(82)90118-X PubMedCrossRef

Hald A, Lotharius J (2005) Oxidative stress and inflammation in Parkinson’s disease: is there a causal link? Exp Neurol 193(2):279–290. https://doi.org/10.1016/j.expneurol.2005.01.013 PubMedCrossRef

Halliwell B (2007) Biochemistry of oxidative stress. Biochem Soc Trans 35(5):1147–1150. https://doi.org/10.1042/BST0351147 PubMedCrossRef

Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, Clay P, Collins A, Smith A, Speit G, Thybaud V, Tice RR (2003) Recommendations for conducting the in vivo alkaline comet assay. Mutagenesis 18(1):45–51. https://doi.org/10.1093/mutage/18.1.45 PubMedCrossRef

Holven KB, Aukrust P, Retterstol K, Hagve TA, Mørkrid L, Ose L, Nenseter MS (2006) Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects. Scand J Clin Lab Invest 66(1):45–54. https://doi.org/10.1080/00335510500429821 PubMedCrossRef

Hsu CS, Li Y (2002) Aspirin potently inhibits oxidative DNA strand breaks: implications for cancer chemoprevention. Biochem Biophys Res Commun 293(2):705–709. https://doi.org/10.1016/S0006-291X(02)00271-1 PubMedCrossRef

Ignarro LJ (1989) Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res:65

Ignarro LJ (2000) Nitric oxide: biology and pathobiology. Academic Press

Isobe C, Murata T, Sato C, Terayama Y (2005) Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer’s disease and Parkinson’s disease. Life Sci 77(15):1836–1843. https://doi.org/10.1016/j.lfs.2005.02.014 PubMedCrossRef

Jimenez-Altayo F, Briones AM, Giraldo J, Planas AM, Salaices M, Vila E (2005) Increased superoxide anion production by Interleukin-1 impairs nitric oxide-mediated relaxation in resistance arteries. J Pharmacol Exp Ther 316(1):42–52. https://doi.org/10.1124/jpet.105.088435 PubMedCrossRef

Kaul S, Zadeh AA, Shah PK (2006) Homocysteine hypothesis for atherothrombotic cardiovascular disease. Not Validated J Am Coll Cardiol 48(5):914–923. https://doi.org/10.1016/j.jacc.2006.04.086 PubMedCrossRef

Keller JN, Kindy MS, Holtsberg FW, St. Clair DK, Yen H-C, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB, Mattson MP (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 18

Kempuraj D, Thangavel R, Natteru PA, Selvakumar GP, Saeed D, Zahoor H, Zaheer S, Iyer SS, Zaheer A (2016) Neuroinflammation induces neurodegeneration. J Neurol Neurosurg spine 1

Klegeris A, McGeer PL (2005) Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease. Curr Alzheimer Res 2(3):355–365. https://doi.org/10.2174/1567205054367883 PubMedCrossRef

Kolling J, Scherer EB, da Cunha AA, da Cunha MJ, Wyse ATS (2011) Homocysteine induces oxidative–nitrative stress in heart of rats: prevention by folic acid. Cardiovasc Toxicol 11(1):67–73. https://doi.org/10.1007/s12012-010-9094-7 PubMedCrossRef

Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20(18):6920–6926PubMed

Kulkarni K, Richard BC (2003) Lifestyle, homocysteine, and the metabolic syndrome. Metab Syndr Relat Disord 1(2):141–147. https://doi.org/10.1089/154041903322294461 PubMedCrossRef

Lehotsky J, Petras M, Kovalska M, Tothova B, Drgova A, Kaplan P (2015) Mechanisms involved in the ischemic tolerance in brain: effect of the homocysteine. Cell Mol Neurobiol 35(1):7–15. https://doi.org/10.1007/s10571-014-0112-3 PubMedCrossRef

Li Y, Liu L, Kang J, Sheng JG, Barger SW, Mrak RE, Griffin WST (2000) Neuronal–glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J Neurosci 20:149–155PubMed

Lindmark E, Diderholm E, Wallentin L, Siegbahn A (2001) Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 286(17):2107–2113. https://doi.org/10.1001/jama.286.17.2107 PubMedCrossRef

Liu C-C, Ho W-Y, Leu K-L, Tsai H-M, Yang T-H (2009) Effects of S -adenosylhomocysteine and homocysteine on DNA damage and cell cytotoxicity in murine hepatic and microglia cell lines. J Biochem Mol Toxicol 23(5):349–356. https://doi.org/10.1002/jbt.20298 PubMedCrossRef

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(3):265–275. https://doi.org/10.1016/0304-3894(92)87011-4 PubMed

MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA (1996) Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci U S A 93(21):11853–11858. https://doi.org/10.1073/pnas.93.21.11853 PubMedPubMedCentralCrossRef

Maluf SW, Erdtmann B (2000) Follow-up study of the genetic damage in lymphocytes of pharmacists and nurses handling antineoplastic drugs evaluated by cytokinesis-block micronuclei analysis and single cell gel electrophoresis assay. Mutat Res Toxicol Environ Mutagen 471(1-2):21–27. https://doi.org/10.1016/S1383-5718(00)00107-8 CrossRef

Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47(3):469–474. https://doi.org/10.1111/j.1432-1033.1974.tb03714.x PubMedCrossRef

Matté C, Mackedanz V, Stefanello FM, Scherer EBS, Andreazza AC, Zanotto C, Moro AM, Garcia SC, Gonçalves CA, Erdtmann B, Salvador M, Wyse ATS (2009a) Chronic hyperhomocysteinemia alters antioxidant defenses and increases DNA damage in brain and blood of rats: protective effect of folic acid. Neurochem Int 54(1):7–13. https://doi.org/10.1016/j.neuint.2008.08.011 PubMedCrossRef

Matté C, Stefanello FM, Mackedanz V, Pederzolli CD, Lamers ML, Dutra-Filho CS, Dos Santos MF, Wyse ATS (2009b) Homocysteine induces oxidative stress, inflammatory infiltration, fibrosis and reduces glycogen/glycoprotein content in liver of rats. Int J Dev Neurosci 27(4):337–344. https://doi.org/10.1016/j.ijdevneu.2009.03.005 PubMedCrossRef

McCully KS (2015) Homocysteine metabolism, atherosclerosis, and diseases of aging. In: Comprehensive physiology. John Wiley & Sons, Inc., Hoboken, pp 471–505. https://doi.org/10.1002/cphy.c150021 CrossRef

Milton NGN (2008) Homocysteine inhibits hydrogen peroxide breakdown by catalase. Open Enzym Inhib J 1(1):34–41. https://doi.org/10.2174/1874940200801010034 CrossRef

Moore AH, O’Banion M (2002) Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease. Adv Drug Deliv Rev 54(12):1627–1656. https://doi.org/10.1016/S0169-409X(02)00162-X PubMedCrossRef

Murray MT, Pizzorno JE (2013) Textbook of natural medicine. In: Textbook of natural medicine

Nadin SB, Vargas-Roig LM, Ciocca DR (2001) A silver staining method for single-cell gel assay. J Histochem Cytochem 49(9):1183–1186. https://doi.org/10.1177/002215540104900912 PubMedCrossRef

Neves LB, Macedo DM, Lopes AC (2004) Homocysteine. J Bras Patol Med Lab 40(5):311–320. https://doi.org/10.1590/S1676-24442004000500006 CrossRef

Obeid R, Herrmann W (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 580(13):2994–3005. https://doi.org/10.1016/J.FEBSLET.2006.04.088 PubMedCrossRef

Picerno I, Chirico C, Condello S, Visalli G, Ferlazzo N, Gorgone G, Caccamo D, Ientile R (2007) Homocysteine induces DNA damage and alterations in proliferative capacity of T-lymphocytes: a model for immunosenescence? Biogerontology 8(2):111–119. https://doi.org/10.1007/s10522-006-9040-z PubMedCrossRef

Poddar R, Paul S (2009) Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death. J Neurochem 110(3):1095–1106. https://doi.org/10.1111/j.1471-4159.2009.06207.x PubMedPubMedCentralCrossRef

Rao GHR, Fareed J (2012) Aspirin prophylaxis for the prevention of thrombosis: expectations and limitations. Thrombosis 2012:104707–104709. https://doi.org/10.1155/2012/104707 PubMedPubMedCentralCrossRef

Richman IB, Owens DK (2017) Aspirin for primary prevention. Med Clin North Am 101(4):713–724. https://doi.org/10.1016/j.mcna.2017.03.004 PubMedCrossRef

Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101(15):1767–1772. https://doi.org/10.1161/01.CIR.101.15.1767 PubMedCrossRef

Rubio-Perez JM, Morillas-Ruiz JM (2012) A review: inflammatory process in Alzheimer’s disease, role of cytokines. ScientificWorldJournal 2012:756357–756315. https://doi.org/10.1100/2012/756357 PubMedPubMedCentralCrossRef

Scherer EBS, da Cunha MJ, Matté C, Schmitz F, Netto CA, Wyse ATS (2010) Methylphenidate affects memory, brain-derived neurotrophic factor immunocontent and brain acetylcholinesterase activity in the rat. Neurobiol Learn Mem 94(2):247–253. https://doi.org/10.1016/j.nlm.2010.06.002 PubMedCrossRef

Scherer EBS, da Cunha AA, Kolling J, da Cunha MJ, Schmitz F, Sitta A, Lima DD, Delwing D, Vargas CR, Wyse ATS (2011) Development of an animal model for chronic mild hyperhomocysteinemia and its response to oxidative damage. Int J Dev Neurosci 29(7):693–699. https://doi.org/10.1016/j.ijdevneu.2011.06.004 PubMedCrossRef

Scherer EBS, Loureiro SO, Vuaden FC, da Cunha AA, Schmitz F, Kolling J, Savio LEB, Bogo MR, Bonan CD, Netto CA, Wyse ATS (2014) Mild hyperhomocysteinemia increases brain acetylcholinesterase and proinflammatory cytokine levels in different tissues. Mol Neurobiol 50(2):589–596. https://doi.org/10.1007/s12035-014-8660-6 PubMedCrossRef

Schliebs R, Arendt T (2006) The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease. J Neural Transm 113(11):1625–1644. https://doi.org/10.1007/s00702-006-0579-2 PubMedCrossRef

Schweinberger BM, Rodrigues AF, dos Santos TM, Rohden F, Barbosa S, da Luz Soster PR, Partata WA, Faccioni-Heuser MC, Wyse ATS (2017) Methionine administration in pregnant rats causes memory deficit in the offspring and alters ultrastructure in brain tissue. Neurotox Res. https://doi.org/10.1007/s12640-017-9830-x

Sharma GS, Kumar T, Dar TA, Singh LR (2015) Protein N-homocysteinylation: from cellular toxicity to neurodegeneration. Biochim Biophys Acta - Gen Subj 1850(11):2239–2245. https://doi.org/10.1016/j.bbagen.2015.08.013 CrossRef

Shi X, Ding M, Dong Z, Chen F, Ye J, Wang S, Leonard SS, Castranova V, Vallyathan V (1999) Antioxidant properties of aspirin: characterization of the ability of aspirin to inhibit silica-induced lipid peroxidation, DNA damage, NF-kappaB activation, and TNF-alpha production. Mol Cell Biochem 199(1/2):93–102. https://doi.org/10.1023/A:1006934612368 PubMedCrossRef

Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175(1):184–191. https://doi.org/10.1016/0014-4827(88)90265-0 PubMedCrossRef

Singh RP, Sharad S, Kapur S (2004) Free radicals and oxidative stress in neurodegenerative diseases: relevance of dietary antioxidants. JIACM 5:218–25

Škovierová H, Vidomanová E, Mahmood S, Sopková J, Drgová A, Červeňová T, Halašová E, Lehotský J (2016) The molecular and cellular effect of homocysteine metabolism imbalance on human health. Int J Mol Sci 17. https://doi.org/10.3390/ijms17101733, 10

Song Y-S, Rosenfeld ME (2004) Methionine-induced hyperhomocysteinemia promotes superoxide anion generation and NF κ B activation in peritoneal macrophages of C57BL/6 mice. J Med Food 7(2):229–234. https://doi.org/10.1089/1096620041224021 PubMedCrossRef

Streck EL, Matte C, Vieira PS, Rombaldi F, Wannmacher CMD, Wajner M, Wyse ATS (2002) Reduction of Na(+),K(+)-ATPase activity in hippocampus of rats subjected to chemically induced hyperhomocysteinemia. Neurochem Res 27(12):1593–1598. https://doi.org/10.1023/A:1021670607647 PubMedCrossRef

Tauseef M, Sharma KK, Fahim M (2007) Aspirin restores normal baroreflex function in hypercholesterolemic rats by its antioxidative action. Eur J Pharmacol 556(1-3):136–143. https://doi.org/10.1016/j.ejphar.2006.11.029 PubMedCrossRef

Tauseef M, Shahid M, Sharma KK, Fahim M (2008) Antioxidative action of aspirin on endothelial function in hypercholesterolaemic rats. Basic Clin Pharmacol Toxicol 103(4):314–321. https://doi.org/10.1111/j.1742-7843.2008.00277.x PubMedCrossRef

Teismann P, Ferger B (2001) Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson’s disease. Synapse 39(2):167–174. https://doi.org/10.1002/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U PubMedCrossRef

Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu J-C, Sasaki YF (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35(3):206–221. https://doi.org/10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J PubMedCrossRef

Touzani O, Boutin H, LeFeuvre R, Parker L, Miller A, Luheshi G, Rothwell N (2002) Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J Neurosci 22(1):38–43PubMed

Tracey KJ, Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW (2000) Vagus nerve stimulation attenuates the systemic inflammatory responseto endotoxin. Nature 405(6785):458–462. https://doi.org/10.1038/35013070 PubMedCrossRef

Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH (1993) Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 39:1764–1779PubMed

Underwood MJ, More RS (1994) The aspirin papers. BMJ 308(6921):71–72. https://doi.org/10.1136/bmj.308.6921.71 PubMedPubMedCentralCrossRef

Vanzin CS, Manfredini V, Marinho AE, Biancini GB, Ribas GS, Deon M, Wyse AT, Wajner M, Vargas CR (2014) Homocysteine contribution to DNA damage in cystathionine β-synthase-deficient patients. Gene 539(2):270–274. https://doi.org/10.1016/j.gene.2014.02.015 PubMedCrossRef

Wainstein MV, Mossmann M, Araujo GN, Gonçalves SC, Gravina GL, Sangalli M, Veadrigo F, Matte R, Reich R, Costa FG, Andrades M, da Silva AMV, Bertoluci MC (2017) Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography. Diabetol Metab Syndr 9(1):67. https://doi.org/10.1186/s13098-017-0266-5 PubMedPubMedCentralCrossRef

Wang X (2001) The expanding role of mitochondria in apoptosis. Genes Dev 15(22):2922–2933PubMed

Wang J, Tan L, Wang H-F, Tan C-C, Meng X-F, Wang C, Tang S-W, Yu J-T (2015) Anti-inflammatory drugs and risk of Alzheimer’s disease: an updated systematic review and meta-analysis. J Alzheimers Dis 44:385–396. https://doi.org/10.3233/JAD-141506 PubMed

Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, Maeda N (1995) Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci U S A 92(5):1585–1589. https://doi.org/10.1073/pnas.92.5.1585 PubMedPubMedCentralCrossRef

Wu R, Lamontagne D, de Champlain J (2002) Antioxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation 105(3):387–392. https://doi.org/10.1161/hc0302.102609 PubMedCrossRef

Wyse ATS, Zugno AI, Streck EL, Matté C, Calcagnotto T, Wannmacher CMD, Wajner M (2002) Inhibition of Na+,K+-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem Res 27:1685–1689. https://doi.org/10.1023/A:1021647329937 PubMedCrossRef

Xu Z, Tong C, Eisenach JC (1996) Acetylcholine stimulates the release of nitric oxide from rat spinal cord. Anesthesiology 85(1):107–111. https://doi.org/10.1097/00000542-199607000-00015 PubMedCrossRef

Yamakura F, Taka H, Fujimura T, Murayama K (1998) Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 273(23):14085–14089. https://doi.org/10.1074/jbc.273.23.14085 PubMedCrossRef

Zhou J, Werstuck GH, Lhotak S, Shi YY, Tedesco V, Trigatti B, Dickhout J, Majors AK, DiBello PM, Jacobsen DW, Austin RC (2008) Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice. FASEB J 22(7):2569–2578. https://doi.org/10.1096/fj.07-105353 PubMedPubMedCentralCrossRef

Titel: Chronic Mild Hyperhomocysteinemia Alters Inflammatory and Oxidative/Nitrative Status and Causes Protein/DNA Damage, as well as Ultrastructural Changes in Cerebral Cortex: Is Acetylsalicylic Acid Neuroprotective?
verfasst von: Daniella de S. Moreira
Paula W. Figueiró
Cassiana Siebert
Caroline A. Prezzi
Francieli Rohden
Fatima C. R. Guma
Vanusa Manfredini
Angela T. S. Wyse
Publikationsdatum: 01.04.2018
Verlag: Springer US
Erschienen in: Neurotoxicity Research / Ausgabe 3/2018
Print ISSN: 1029-8428
Elektronische ISSN: 1476-3524
DOI: https://doi.org/10.1007/s12640-017-9847-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Thallium-Induced Toxicity in Rat Brain Crude Synaptosomal/Mitochondrial Fractions is Sensitive to Anti-excitatory and Antioxidant Agents

Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study

Atorvastatin Prevents Early Oxidative Events and Modulates Inflammatory Mediators in the Striatum Following Intranasal 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Administration in Rats

Experimental Evidence that In Vivo Intracerebral Administration of L-2-Hydroxyglutaric Acid to Neonatal Rats Provokes Disruption of Redox Status and Histopathological Abnormalities in the Brain

Liver X Receptor Agonist GW3965 Regulates Synaptic Function upon Amyloid Beta Exposure in Hippocampal Neurons